The global non-invasive prenatal testing market is currently witnessing strong growth.
Non-invasive prenatal testing (NIPT) is a form of prenatal screening conducted on a pregnant woman’s blood sample to detect the presence of fetal abnormalities. The test is primarily used to diagnose genetic disorders such as Down syndrome (or trisomy 21), Edwards syndrome (or trisomy 18), Patau syndrome (or trisomy 13) and Turner syndrome, by analyzing DNA fragments in the mother’s blood. The procedure eliminates the need for various precarious and invasive procedures, such as chorionic villus sampling (CVS) and can be performed after nine weeks of pregnancy.
The growing prevalence of genetic disorders of the fetus is one of the key factors driving the market growth. Furthermore, technological advancements in the field of life sciences and healthcare industry is also providing a boost to the market. For instance, the development of DNA sequencing technologies, regenerative medicines and breakthroughs in molecular research have created immense possibilities to combat the chances of any serious disease at the primitive stage itself. Additionally, the increasing acceptance rate for prenatal testing, along with rising health consciousness and awareness regarding the benefits and significance of such testing among the masses, is also driving the market growth. Healthcare providers, as well as expecting parents, are adopting alternatives to diagnose other genetic disorders, including spina bifida, cleft palate, and sickle cell anemia, and treat them in the early stages of fetal development. Moreover, the shifting trend toward childbearing at high maternal age (35 years or older) is also positively impacting the market growth. Advancing maternal age can lead to numerous health complications, such as high blood pressure, reduced fertility, risk of miscarriage and increased risk of chromosomal anomalies in the fetus. Looking forward, the analyst expects the market to register a CAGR of around 12% during 2020-2025.
Breakup by Product Type: Consumables Instruments
Breakup by Test Type: Materni 21 Harmony Panaroma Verifi NIFTY Others
Breakup by Technology: NGS WGS Others
Breakup by Test Type: Ultrasound Detection Biochemical Screening Tests Cell-Free DNA in Maternal Plasma Tests Fetal Cells in Maternal Blood Tests Others
Breakup by Application: Trisomy Microdeletions Syndrome Others
Breakup by End-User: Hospitals Diagnostic Laboratories Others
Breakup by Region: North America United States Canada Asia Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa
Competitive Landscape: The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., Berry Genetics Inc., BGI Genomics Co. Ltd., Eurofins LifeCodexx GmbH, F. Hoffmann-La Roche AG, GE Healthcare, Igenomix, Illumina Inc., Laboratory Corporation, Natera Inc., Perkinelmer Inc., Thermo Fisher Scientific Inc., Yourgene Health, etc.
Key Questions Answered in This Report: How has the global non-invasive prenatal testing market performed so far and how will it perform in the coming years? What are the key regional markets? What is the breakup of the market based on the product type? What is the breakup of the market based on the test type? What is the breakup of the market based on the technology? What is the breakup of the market based on the method? What is the breakup of the market based on the application? What is the breakup of the market based on the end-user? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global non-invasive prenatal testing market and who are the key players? What is the degree of competition in the industry?
Our reports have been used by over 10K customers, including:
The Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2020 report. The report provides a detailed understanding and analysis of how, why and on what terms companies enter discovery stage partnering deals. These deals are discovery stage whereby the licensee obtains a right or an option...
152 pages •
By Global Industry Analysts
• Sep 2020
Global Rice Market to Reach 557.3 Million Tonnes by the Year 2027 Amid the COVID-19 crisis, the global market for Rice estimated at 491.9 Million Tonnes in the year 2020, is projected to reach a revised size of 557.3 Million Tonnes by 2027, growing at a CAGR of 1.8% over the period 2020-2027. The U.S. Accounts for Over 29%...
Voice Biometric Solution Market Research Report by Component (Hardware and Software), by Industry (Automotive, BSFI, Consumer Electronics, Government, and Healthcare) - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Voice Biometric Solution Market is expected to grow from USD 1,563.56 Million in...
163 pages •
By Global Industry Analysts
• Sep 2020
Global Life Science Software Market to Reach $8.5 Billion by 2027 Amid the COVID-19 crisis, the global market for Life Science Software estimated at US$5.5 Billion in the year 2020, is projected to reach a revised size of US$8.5 Billion by 2027, growing at aCAGR of 6.6% over the period 2020-2027. Cloud-based, one of the segments analyzed...
236 pages •
By Global Industry Analysts
• Sep 2020
Global Digital Certificates and Public Key Infrastructure Market to Reach $14.6 Billion by 2027 Amid the COVID-19 crisis, the global market for Digital Certificates and Public Key Infrastructure estimated at US$4 Billion in the year 2020, is projected to reach a revised size of US$14.6 Billion by 2027, growing at aCAGR of 20.3% over...
Separation Systems for Commercial Biotechnology Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Separation Systems for Commercial Biotechnology...
Europe, the liquid biopsy market, is anticipated to reach US$ 2,251.12 Mn in 2027 from US$ 1,097.82 Mn in 2019. The market is projected to grow with a CAGR of 9.5% from 2019-2027. The liquid biopsy market is growing primarily due to government and global health organizations initiatives.Restraining factors, such as low sensitivity of liquid...
Cerebral Palsy - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Cerebral Palsy - Pipeline Review, H2 2020, provides an overview of the Cerebral Palsy (Central Nervous System) pipeline landscape. Cerebral palsy is a group of disorders that...
Biometric Sensors Market Research Report by Type (Capacitive sensors, Electric field Sensors (eField), Optical sensors, Thermal sensors, and Ultrasound sensors), by Application (Facial Scan, Finger Scan, Hand Scan, Iris Scan, and Vein Scan), by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global...
Cancer Biomarker Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Cancer Biomarker market including the COVID-19 pandemic implications for Cancer...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.